Suhua Li

Title: Suhua Li: Innovator in Anticancer Medicinal Agents

Introduction

Suhua Li is a prominent inventor based in Guangzhou, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to advancing cancer research.

Latest Patents

Suhua Li holds a patent for "Arylfluorosulfate compounds and methods." This patent describes a high-throughput screening method for identifying candidate anticancer medicinal agents. The candidate agents are arylfluorosulfate compounds derived from phenolic compounds. The method involves the in situ generation of these compounds in multi-well plates through the reaction of phenolic compounds in DMSO with a saturated solution of SOF dissolved in a solvent such as acetonitrile, in the presence of an organic base. This innovative approach allows for the efficient identification of potential anticancer agents without the need for further purification.

Career Highlights

Suhua Li is affiliated with The Scripps Research Institute, where she continues to contribute to groundbreaking research in medicinal chemistry. Her work has garnered attention for its potential impact on cancer treatment and drug development. With a focus on creating effective therapeutic agents, she is at the forefront of innovation in her field.

Collaborations

Suhua Li collaborates with esteemed colleagues, including Jie Li and Zilei Liu. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field of anticancer therapies.

Conclusion

Suhua Li's innovative work in developing arylfluorosulfate compounds represents a significant advancement in the search for effective anticancer agents. Her contributions to medicinal chemistry are paving the way for future breakthroughs in cancer treatment.